Could cause temporary or reversible harm; serious harm is unlikely.
Failed stability specifications: Out of specification for hardness test
| Brand name | LANTHANUM CARBONATE |
| Generic name | LANTHANUM CARBONATE |
| Active ingredient(s) | LANTHANUM CARBONATE |
| Distributed by / for | Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton |
| NDC | 76282-478-90 |
| Full product label | Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13. |
| Recalling firm | Cipla USA, Inc. |
| Distribution | Nationwide in the USA |
| Quantity | N/A |
| Recall initiated | 2025-10-24 |
| Report date | 2025-12-17 |
| Recall completed | — |
| Recall number | D-0218-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗